Mutational analysis of 26 residues of vaccinia DNA topoisomerase identifies Ser-204 as important for DNA binding and cleavage

Biochemistry. 1997 Jul 1;36(26):7944-50. doi: 10.1021/bi970498q.

Abstract

Vaccinia DNA topoisomerase, a 314 amino acid type I enzyme, catalyzes the cleavage and rejoining of DNA strands through a DNA-(3'-phosphotyrosyl)-enzyme intermediate formed at a specific target sequence, 5'-(C/T)CCTT downward arrow. To identify amino acids that participate in the DNA binding and transesterification steps, we introduced alanine substitutions at 18 positions within a centrally located 27 amino acid segment (181-RLYKPLLKLTDDSSPEEFLFNKLSERK-207) and at 8 positions near the N-terminus (1-MRALFYKDGK-10). All mutant proteins except two displayed wild-type activity in relaxing supercoiled DNA. F200A and S204A exhibited reduced rates of relaxation and were subjected to a kinetic analysis of the strand cleavage reaction under single-turnover and equilibrium conditions. The F200A and S204A mutations reduced the rate of single-turnover DNA cleavage by factors of 5 and 70, respectively. Both mutations shifted the cleavage-religation equilibrium in favor of the noncovalently bound state. The S204A mutation reduced the affinity of topoisomerase for CCCTT-containing DNA, but did not alter the site-specificity of DNA cleavage. Vaccinia residue Ser-204, which is conserved in all poxvirus topoisomerases, but not in the cellular homologues, may contribute to the unique cleavage site specificity of the poxvirus enzymes. Phe-200 is conserved in all members of the type IB topoisomerase family.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alanine / genetics
  • Alanine / metabolism
  • Amino Acid Sequence
  • Base Sequence
  • Binding Sites
  • DNA Mutational Analysis
  • DNA Topoisomerases, Type I / genetics*
  • DNA Topoisomerases, Type I / metabolism*
  • DNA, Superhelical / genetics
  • DNA, Superhelical / metabolism
  • DNA, Viral / genetics*
  • DNA, Viral / metabolism*
  • Magnesium / pharmacology
  • Molecular Sequence Data
  • Mutagenesis, Site-Directed
  • Serine / genetics*
  • Serine / metabolism*
  • Sodium Chloride / pharmacology
  • Vaccinia virus / enzymology*
  • Vaccinia virus / genetics
  • Viral Proteins / genetics*
  • Viral Proteins / metabolism*

Substances

  • DNA, Superhelical
  • DNA, Viral
  • Viral Proteins
  • Sodium Chloride
  • Serine
  • DNA Topoisomerases, Type I
  • Magnesium
  • Alanine